K
Khushwant S. Yadav
Researcher at Narsee Monjee Institute of Management Studies
Publications - 61
Citations - 1354
Khushwant S. Yadav is an academic researcher from Narsee Monjee Institute of Management Studies. The author has contributed to research in topics: Drug delivery & Medicine. The author has an hindex of 15, co-authored 49 publications receiving 870 citations. Previous affiliations of Khushwant S. Yadav include Maharaja Sayajirao University of Baroda & University of Oklahoma.
Papers
More filters
Journal ArticleDOI
Nanogels as potential nanomedicine carrier for treatment of cancer: A mini review of the state of the art.
Govind Soni,Khushwant S. Yadav +1 more
TL;DR: There is an urgent need for relevant clinical data from nanogels so as to allow translation of the nanogel concept into a viable therapeutic application for the treatment of cancer.
Journal ArticleDOI
Glaucoma: Current treatment and impact of advanced drug delivery systems.
TL;DR: The present review briefs the current treatments in terms of drugs used and in detail the impact of utilizing the above mentioned novel drug delivery systems in the treatment of glaucoma.
Journal ArticleDOI
Modified Nanoprecipitation Method for Preparation of Cytarabine-Loaded PLGA Nanoparticles
TL;DR: Development of cytarabine-loaded poly(lactide-coglycolide) (PLGA)-based biodegradable nanoparticles by a modified nanoprecipitation which would have sustained release of the drug and stability studies showed that the developed PLGA NPs would remain stable in terms of both mean particle size and drug content for 2 months.
Journal ArticleDOI
Unfolding the electrospinning potential of biopolymers for preparation of nanofibers
TL;DR: Insight is provided towards novel biopolymers, such as tree gum, wheat protein, soy protein, zein along with their application in drug delivery along with various manufacturing variables that affect the morphology of nanofibers and other processing parameters have been discussed.
Journal ArticleDOI
Formulation optimization of etoposide loaded PLGA nanoparticles by double factorial design and their evaluation.
TL;DR: Drug release study showed that etoposide loaded PLGA nanoparticles sustained release up to 72h and stability studies indicated that it was best to store nanoparticle formulations in the freeze dried state where they remained stable in terms of both size and drug content upto three months.